BiotechTube

OPT-80

Phase 2Completed
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Diarrhea

Conditions

Diarrhea

Trial Timeline

Nov 1, 2004 → Apr 1, 2005

NCT ID
NCT00097422

About OPT-80

OPT-80 is a phase 2 stage product being developed by Merck for Diarrhea. The current trial status is completed. This product is registered under clinical trial identifier NCT00097422. Target conditions include Diarrhea.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT00097422Phase 2Completed

Competing Products

20 competing products in Diarrhea

See all competitors
ProductCompanyStageHype Score
YM060 + PlaceboAstellas PharmaPhase 3
77
Fidaxomicin oral suspension + Fidaxomicin tablets + Vancomycin oral liquid + Vancomycin capsulesAstellas PharmaPhase 3
77
YM060Astellas PharmaPhase 3
77
RamosetronAstellas PharmaPre-clinical
23
Racecadotril Film-Coated Tablet (FCT) + Racecadotril CapsuleJohnson & JohnsonPhase 1
33
loperamide-simethicone + matching placeboJohnson & JohnsonApproved
85
Racecadotril + Racecadotril + Racecadotril + RacecadotrilJohnson & JohnsonPhase 1
33
Loperamide/simeticone 2 mg/125 mg caplets + Loperamide/simeticone 2 mg/125 mg chewable tablets + Probiotic Saccharomyces boulardii 250 mg capsulesJohnson & JohnsonApproved
85
fidaxomicin + PlaceboMerckPhase 3
77
Surotomycin + PlaceboMerckPhase 1
33
Surotomycin + PlaceboMerckPhase 1
33
fidaxomicinMerckPhase 2
52
RV5 (Pentavalent Rotavirus Vaccine)MerckApproved
85
LJN452 + Placebo to LJN452NovartisPhase 2
52
Octreotide Long Acting ReleaseNovartisPhase 3
77
DNK333 + PlaceboNovartisPhase 2
52
Probiotic SupplementRochePre-clinical
23
Etrasimod + Placebo + CorticosteroidsPfizerPhase 2
51
Calcium Carbonate + nelfinavir + lamivudine + loperamide + nelfinavir + lamivudine + zidovudinePfizerPhase 3
76
TigecyclinePfizerPre-clinical
22

Other Products from Merck

DuleraApproved
85
ImipenemApproved
85
Mavenclad®Approved
85
raltegravir + PlaceboApproved
85
alendronate sodiumApproved
85